Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jonas Schadt
Observed name:
Schadt, Jonas
Institutions:
University Hospital Carl Gustav Carus,
Else Kröner Fresenius Center for Digital Health,
Technische Universität Dresden
Observed institutions:
University Hospital Carl Gustav Carus,
Else Kröner Fresenius Center for Digital Health,
Technische Universität Dresden
ORCID:
0000-0002-2687-9178
Observed ORCID:
0000-0002-2687-9178
OpenAlex ID:
A5032713602
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia
2022
·
Maximilian A. Röhnert
, Michael Kramer
, et al.
·
Leukemia
·
42
PDF
MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms
2024
·
Uta Oelschlaegel
, Susann Winter
, et al.
·
Leukemia
·
8
PDF
Measurable residual disease by multicolor flow cytometry in acute myeloid leukemia: A comparison of peripheral blood and bone marrow
2026
·
Jonas Schadt
, Malte von Bonin
, et al.
·
Cytometry Part B Clinical Cytometry
·
5
PDF
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR
2025
·
Maximilian A. Röhnert
, Chiara Löffler
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
PDF
Model-based integration of chimeric antigen receptor T-cell kinetics and tumor features to predict therapeutic outcomes in patients with B-cell malignancies
2026
·
Jonas Schadt
, Maximilian Alexander Röhnert
, et al.
·
Frontiers in Immunology
PDF
3086 – Resnet to the Rescue: an Automated Approach for the Detection of Measurable Residual Disease in Patients With Acute Myeloid Leukemia
2026
·
Ingmar Glauche
, Lars Thielecke
, et al.
·
Experimental Hematology
Sachbericht zum Verwendungsnachweis dataXperiment - Erprobung innovativer Machbarkeits- und Anwendungsszenarien in der Onkologie - Nationale Dekade gegen Krebs
2026
·
Röhnert, Maximilian Alexander
, Schadt, Jonas
·
RENATE
Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications
2026
·
Jonas Schadt
, Malte von Bonin
, et al.
·
Leukemia
PDF
Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMML
2025
·
Uta Oelschlaegel
, Jonas Schadt
, et al.
·
HemaSphere
PDF
HLA-DR Expression on Leukemic Progenitor Cells before Allogeneic Hematopoietic Cell Transplantation Adds Prognostic Value in the Presence of MRD
2024
·
Maximilian Alexander Rohnert
, Jonas Schadt
, et al.
·
Blood
PDF
P528: Can Multiparametric Flow Cytometry of Peripheral Blood Challenge Bone Marrow Analyses for Detection of Measurable Residual Disease in Patients With Acute Myeloid Leukemia?
2023
·
Jonas Schadt
, Maximilian Alexander Röhnert
, et al.
·
HemaSphere
P538: Fast-track Measurable Residual Disease Detection by Multiparametric Flow Cytometry in Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
2023
·
Maximilian Roehnert
, Michael Kramer
, et al.
·
HemaSphere
Pb1767: Challenges in Machine Learning-based Detection of Measurable Residual Disease in Patients With Acute Myeloid Leukemia
2023
·
Lars Thielecke
, Friedemann Uschner
, et al.
·
HemaSphere
Fast-Track Measurable Residual Disease Detection By Multiparametric Flow Cytometry in Acute Myeloid Leukemia before Allogeneic Hematopoietic Cell Transplantation
2022
·
Maximilian Alexander Röhnert
, Michael Kramer
, et al.
·
Blood
Show more works
View as search
Works count:
14
Citation count:
57
H-index:
3
I10-index:
1
Year
Topic
Type